Angelo Paolo Dei Tos Selected Research

Antibodies

3/2022	Primary synovial sarcoma of bone: a retrospective analysis of 25 patients.
7/2009	The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets?
6/2007	Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors: fact or artifact?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angelo Paolo Dei Tos Research Topics

Disease

42	Neoplasms (Cancer) 04/2024 - 06/2007
30	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 09/2010
13	Neoplasm Metastasis (Metastasis) 04/2024 - 03/2012
10	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 05/2015
4	Myxoid Liposarcoma 01/2024 - 07/2009
4	Liposarcoma 03/2021 - 09/2010
4	Leiomyosarcoma 07/2017 - 09/2010
3	T-Cell Lymphoma (Lymphoma, T Cell) 12/2023 - 09/2008
3	Lymphoma (Lymphomas) 12/2023 - 07/2022
3	Breast Neoplasms (Breast Cancer) 06/2023 - 11/2012
3	Adenocarcinoma 03/2023 - 01/2020
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2023 - 02/2021
3	Melanoma (Melanoma, Malignant) 12/2022 - 05/2021
3	Synovial Sarcoma (Synovioma) 03/2022 - 09/2010
3	Microsatellite Instability 01/2022 - 11/2019
3	Osteosarcoma (Osteogenic Sarcoma) 09/2021 - 01/2015
3	Disease Progression 01/2021 - 01/2013
3	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2017
3	Neutropenia 01/2019 - 01/2017
3	Hemangiosarcoma (Angiosarcoma) 07/2017 - 07/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 04/2023
2	Rectal Neoplasms (Rectal Cancer) 04/2024 - 03/2023
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2024 - 12/2023
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 10/2023
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 01/2022
2	Margins of Excision 03/2022 - 10/2020
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022 - 07/2017
2	Carcinoma (Carcinomatosis) 01/2022 - 09/2013
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 07/2009
2	Chondroblastoma 09/2021 - 10/2017
2	Ewing Sarcoma (Sarcoma, Ewing) 06/2021 - 01/2021
2	Adenosarcoma 11/2020 - 01/2018
2	Adenoma (Adenomas) 01/2020 - 09/2013
2	Carcinogenesis 01/2020 - 11/2012
2	Hypertension (High Blood Pressure) 01/2019 - 05/2012
2	Thrombocytopenia (Thrombopenia) 10/2018 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2014
2	Diabetic Foot 01/2018 - 01/2014
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 01/2014
2	Giant Cell Tumor of Bone 10/2017 - 01/2016
2	Cysts 08/2008 - 02/2007
1	Amyloidosis 03/2024
1	Lupus Nephritis 03/2024
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024
1	Inflammation (Inflammations) 02/2024

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 09/2023 - 09/2010
9	Ifosfamide FDA LinkGeneric 01/2024 - 12/2011
7	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2020
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2017
6	TrabectedinIBA 01/2022 - 12/2011
4	AnthracyclinesIBA 01/2024 - 12/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 12/2021
4	Immune Checkpoint InhibitorsIBA 08/2023 - 11/2019
4	Hormones (Hormone)IBA 06/2023 - 01/2019
4	Gemcitabine FDA Link 01/2020 - 01/2017
4	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 03/2012
4	Tyrosine Kinase InhibitorsIBA 01/2018 - 05/2012
3	NivolumabIBA 04/2024 - 01/2022
3	ParaffinIBA 01/2024 - 01/2022
3	Anaplastic Lymphoma KinaseIBA 12/2023 - 07/2016
3	Inosine Triphosphate (ITP)IBA 01/2023 - 02/2021
3	Phosphotransferases (Kinase)IBA 07/2022 - 07/2009
3	AntibodiesIBA 03/2022 - 06/2007
3	Protein Isoforms (Isoforms)IBA 10/2021 - 10/2013
3	CateninsIBA 09/2021 - 11/2020
3	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 01/2013
3	Aquaporin 1IBA 07/2010 - 01/2006
2	Messenger RNA (mRNA)IBA 02/2024 - 01/2020
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 11/2023 - 10/2023
2	Formaldehyde (Formol)FDA Link 10/2023 - 01/2022
2	Calcibiotic Root Canal SealerIBA 03/2023 - 01/2020
2	Endocrine DisruptorsIBA 12/2022 - 11/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2022 - 01/2017
2	olaparibIBA 01/2022 - 10/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021 - 07/2019
2	Vascular Endothelial Growth Factor CIBA 01/2020 - 07/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 07/2009
2	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 01/2017
2	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2017
2	Alanine Transaminase (SGPT)IBA 01/2019 - 10/2018
2	Sunitinib (Sutent)FDA Link 06/2018 - 01/2018
2	Epirubicin (Ellence)FDA LinkGeneric 01/2018 - 01/2017
2	Coloring Agents (Dyes)IBA 09/2013 - 06/2007
2	Aquaporins (Water Channels)IBA 02/2007 - 01/2006
1	Interleukin-3 (Interleukin 3)IBA 05/2024
1	Interleukin-2 (IL2)IBA 05/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2024
1	Amyloid (Amyloid Fibrils)IBA 03/2024
1	Immunoglobulin A (IgA)IBA 03/2024
1	Congo RedIBA 03/2024
1	Interleukin-23 (Interleukin 23)IBA 02/2024
1	Interleukin-15 (Interleukin 15)IBA 02/2024

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 03/2024 - 07/2009
18	Therapeutics 02/2024 - 09/2008
11	Radiotherapy 03/2022 - 12/2012
8	Neoadjuvant Therapy 01/2024 - 01/2017
4	Immunotherapy 04/2024 - 01/2020
2	Adjuvant Chemotherapy 01/2015 - 03/2012
1	Prostheses and Implants (Prosthesis) 03/2024
1	Breast Implants (Breast Implant) 03/2024